2024/0900 - DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG COMP]
TED · 633424-2026Award noticeawardedNo deadline given
Value
Estimated€561,926 · 561,926.4 EUR
Awarded—
WinnerJANSSEN-CILAG FARMACEUTICA LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 26 | — | 2026-09-15 |
| GILEAD SCIENCES, LDA | 24 | — | 2026-09-15 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 20 | €1,569,649 | 2026-09-15 |
| JANSSEN-CILAG FARMACEUTICA LDA | 14 | €371,730 | 2026-09-08 |
| NOVARTIS FARMA - PROD.FARM SA | 14 | — | 2026-09-08 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG COMP]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-08 | 2024/0900 - DARUNAVIR + COBICISTATE [800 MG + 150 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-07-28 | 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-08-11 | 2024/0900 - EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-08-04 | 2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-07-28 | 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-30 | 2024/0900 - DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |